Ronald Burggrave
Ronald Burggrave has over 30 years of experiences in developing and executing marketing and sales strategies of innovative life sciences technologies.
PiEXT BV - director:
Sales, Marketing and Business Development Consultant.
Agent for Start-Up Companies.
Contact details and information
Piext B.V.
Maliskampsestraat 6
5248 AD Rosmalen
The Netherlands
+31 (0)6 21 929 402
ronald@piext.nl
Chamber of Commerce: 172.00.289
IBAN ING-Bank: NL65INGB067 33 34 147
VAT-id-nr: NL8174.19.275B.01
EORI-nr: NL8174.19.275
Projects and Publications
LA Screen, a RvO (AgentschapNL) funded project, to develop a methodology
to characterize (detect and type) pathogenic bacteria in the food chain.
Concluded Spring 2014.
WebSite: Plos1 LA-MRSA
PathoNGenTrace, a EU FP7 research project:
Next Generation Genome Based High Resolution Tracing of Pathogens.
Website: PNGT
Diagnostic Microbiology and Infectious Disease:
Link to publication.
Previous principals
MBS Molecular Biology Systems B.V., Goes.
NEXT-GEN-PCR: Innovations accelerating Life Science Research and Diagnostics
Website: www.nextgenpcr.com
ENPICOM B.V., ‘s-Hertogenbosch.
Helping the Development of ImmunoTherapeutics.
Website: www.enpicom.com
Genetic Signatures Ltd, Sydney, Australia
Transforming Molecular Diagnostics:
novel tools for pathogen screening.
WebSite: www.geneticsignatures.com
Personalis' Exome Sequencing, for genome guided medicine.
Sr Account Executive for the BNL.
WebSite: www.personalis.com
OpGen INC, Whole Genome Optical Mapping Products and Services
Exclusive dealer for OpGen's technology.
WebSite: www.opgen.com
Biolegio BV, Nijmegen, the Netherlands: Custom Made Oligos and Probes.
WebSite: www.biolegio.com